Oceansbio Inc. (AI) — Funding, Investors & Signals 2026

Oceansbio Inc.

오션스바이오는 빠르게 성장하고 있는 전자약 시장에 뛰어든 스타트업입니다. 오션스바이오는 뇌 신경망 연구 기술을 바탕으로 미주신경에 작용하는 정신질환 치료를 위한 전자약, 초소형 웨어러블 디바이스를 개발하고 있습니다.

Founded 2018

Korea South 7 employees Seed Total: $230.00M AI, Health Care

Oceansbio Inc. is a rapidly growing startup that has entered the emerging field of electronic medicine with a focus on developing electronic drugs and ultra-small wearable devices for treating mental disorders affecting the peripheral nervous system. Founded in 2018, the company is leveraging cutting-edge brain neural network research to develop electronic drugs that directly impact the peripheral nervous system through electrical stimulation for treating neurological disorders. Its products include TaVNS wearables for managing depression and stress and iVNS for treating epilepsy, which integrates secondary battery technology, positioning Oceansbio Inc. as the sole dominant player in the Health Care industry in South Korea. The latest Seed Round investment on 15 May 2023 was led by D·CAMP, Seoul Techno Holdings, Korea Credit Guarantee Fund, and Pusan National University, signifying strong support and belief in the potential of Oceansbio Inc.'s pioneering work in the electronic medicine space. With its innovative approach, strategic partnerships, and well-defined market position, Oceansbio Inc. is poised for significant growth and impact in the electronic medicine market.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	Undisclosed	4	D·CAMP, Seoul Techno Holdings +2	15 May 2023
Non Equity Assistance	Undisclosed	1	TIPS Program	09 Dec 2021
Seed Round	KRW230.00M	2	Series Ventures, TheVentures	28 Jul 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

Undisclosed

D·CAMP, Seoul Techno Holdings +2

15 May 2023

Non Equity Assistance

Undisclosed

TIPS Program

09 Dec 2021

Seed Round

KRW230.00M

Series Ventures, TheVentures

28 Jul 2021

FAQ About Oceansbio Inc.

Oceansbio Inc. was founded in 2018.

Oceansbio Inc. is headquartered in Korea South.

Oceansbio Inc. operates in AI and Health Care. Its work centres on 전자약, 뇌 신경망 연구, 미주신경 and 웨어러블 디바이스.

Oceansbio Inc. has approximately 7 employees.

Oceansbio Inc. has completed 3 funding rounds, raising a total of $230.00M. The latest funding stage is Seed.

Top alternatives and competitors to Oceansbio Inc. include MYAVANA, SiDLY Healthcare, Heali, Skin Dossier, Genoplan . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Oceansbio Inc. and MYAVANA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Oceansbio Inc.

General Information

Discover More

About Oceansbio Inc.

Funding Rounds & Investors (3)

Oceansbio Inc. Alternatives & Competitors

FAQ About Oceansbio Inc.